Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1994;23:865-868

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rhaleb, N. E.
Right arrow Articles by Carretero, O. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rhaleb, N. E.
Right arrow Articles by Carretero, O. A.

Hypertension, Vol 23, 865-868, Copyright © 1994 by American Heart Association


ARTICLES

Role of kinins and nitric oxide in the antihypertrophic effect of ramipril

NE Rhaleb, XP Yang, AG Scicli and OA Carretero
Hypertension and Vascular Research Division, Henry Ford Hospital, Detroit, MI 48202-2689.

We examined the effect of non-antihypertensive doses of the angiotensin- converting enzyme inhibitor ramipril, kinins, and/or nitric oxide on left ventricular hypertrophy in rats with aortic coarctation. We investigated the effect of either HOE 140, a specific B2 receptor antagonist, or NG-nitro-L-arginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, on the antihypertrophic effect of ramipril at non-antihypertensive doses (10 micrograms/kg per day) failed to alter left ventricular hypertrophy significantly, although a small decrease was obtained. Given at a dose of 1 mg/kg per day for 6 weeks, ramipril prevented increased blood pressure and left ventricular hypertrophy after aortic coarctation. Neither of these effects was blocked by simultaneous administration of HOE 140 (500 micrograms/kg per day). In rats with aortic coarctation treated with L-NAME, blood pressure increased further but left ventricular weight did not. Ramipril (1 mg/kg per day) significantly reduced left ventricular hypertrophy, although blood pressure was still higher than in rats given water alone. The slope of the correlation between left ventricular weight and blood pressure in rats that received L-NAME was significantly lower than in rats that did not (0.52 versus 1.29; P = .008). This suggests that for each 1 mm Hg that the blood pressure increased, the increase in left ventricular weight was less in the L-NAME groups. Thus, only antihypertensive doses of ramipril possessed antihypertrophic activity. Kinins did not participate in the chronic antihypertensive and antihypertrophic effects of ramipril. In hypertension induced or aggravated by chronic nitric oxide synthase, L-NAME partially impaired development of left ventricular hypertrophy for reasons that are unclear.


This article has been cited by other articles:


Home page
HypertensionHome page
H. Peng, O. A. Carretero, D. R. Brigstock, N. Oja-Tebbe, and N.-E. Rhaleb
Ac-SDKP Reverses Cardiac Fibrosis in Rats With Renovascular Hypertension
Hypertension, December 1, 2003; 42(6): 1164 - 1170.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N.-E. Rhaleb, X.-P. Yang, M. Nanba, E. G. Shesely, and O. A. Carretero
Effect of Chronic Blockade of the Kallikrein-Kinin System on the Development of Hypertension in Rats
Hypertension, January 1, 2001; 37(1): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
W. B. Strawn, C. M. Ferrario, and E. A. Tallant
Angiotensin-(1–7) Reduces Smooth Muscle Growth After Vascular Injury
Hypertension, January 1, 1999; 33(1): 207 - 211.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N.-E. Rhaleb, H. Peng, M. E. Alfie, E. G. Shesely, and O. A. Carretero
Effect of ACE Inhibitor on DOCA-Salt– and Aortic Coarctation–Induced Hypertension in Mice : Do Kinin B2 Receptors Play a Role?
Hypertension, January 1, 1999; 33(1): 329 - 334.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. H. Ritchie, R. J. Schiebinger, M. C. Lapointe, and J. D. Marsh
Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide
Am J Physiol Heart Circ Physiol, October 1, 1998; 275(4): H1370 - H1374.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
L. J. Heller, J. A. Opsahl, S. E. Wernsing, R. Saxena, and S. A. Katz
Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R849 - R856.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Erlich and T. Rosenthal
Contribution of Nitric Oxide to the Beneficial Effects of Enalapril in the Fructose-Induced Hyperinsulinemic Rat
Hypertension, November 1, 1996; 28(5): 754 - 757.
[Abstract] [Full Text]


Home page
HypertensionHome page
S. B. Harrap and J. B. O'Sullivan
Cardiac Transplantation, Perindopril, and Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats
Hypertension, October 1, 1996; 28(4): 622 - 626.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. F. Dominiczak, A. M. Devlin, W. K. Lee, N. H. Anderson, D. F. Bohr, and J. L. Reid
Vascular Smooth Muscle Polyploidy and Cardiac Hypertrophy in Genetic Hypertension
Hypertension, March 1, 1996; 27(3): 752 - 759.
[Abstract] [Full Text]